Huaizhong Health Group, Inc. financial data

Symbol
ADAD on OTC
Location
Tianan Technology Park, 13/F Headquarter, Center Building 16, 555 Panyu North Ave, Panyu District, Guangzhou City, China
State of incorporation
NV
Fiscal year end
October 31
Former names
Adaiah Distribution Inc (to 9/18/2020)
Latest financial report
10-Q - Q4 2022 - May 26, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.53 %
Debt-to-equity -104 % -3.66%
Return On Equity 39 % -33.7%
Return On Assets -1.07K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.5M shares
Common Stock, Shares, Outstanding 31.5M shares 0%
Entity Public Float 1.41M USD +114%
Common Stock, Value, Issued 31.5K USD

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 3.75K USD +203%
Operating Income (Loss) -30K USD -2.48%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30K USD -2.48%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -30K USD -2.48%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 500 USD
Assets 500 USD
Accounts Payable, Current 19.6K USD
Liabilities, Current 90.5K USD +50.8%
Liabilities 90.5K USD +50.8%
Retained Earnings (Accumulated Deficit) -379K USD -8.59%
Stockholders' Equity Attributable to Parent -90K USD -50%
Liabilities and Equity 500 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 0 USD
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 31.5M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 77.4K USD +8.6%
Deferred Tax Assets, Operating Loss Carryforwards 77.4K USD +8.6%
Additional Paid in Capital 258K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD